ANNALS OF OPHTHALMOLOGY, vol.26, no.6, pp.248-249, 1994 (SCI-Expanded)
Topical cyclosporine appears to increase the graft survival rate in high-risk keratoplasty, but its toxicity may limit its long-term use.